Stadler, Rudolf, et al. “Long-Term Survival Benefit After Adjuvant Treatment of Cutaneous Melanoma With Dacarbazine and Low Dose Natural Interferon Alpha: A Controlled, Randomised Multicentre Trial”. Acta Oncologica, vol. 45, no. 4, Jan. 2006, pp. 389-9, doi:10.1080/02841860600630954.